Woman and Man
- | Country :
- Russian Federation
- Australia
- Canada
- The 3 others...
- | organs : -
- | Specialty : -
Extract
The objective of the current study is to investigate the efficacy, safety and tolerability of several doses of BI 1356 BS (0.5, 2.5 and 5 mg daily) compared to placebo over 12 weeks of treatment in patients with Type 2 diabetes and insufficient glycemic control. In addition, there will be an open-label treatment arm with metformin for sensitivity measurement with this patient population. Population pharmacokinetics of BI 1356 BS will also be assessed in this study.
Inclusion criteria
- Diabetes Mellitus, Type 2